A randomised trial of intravesical irrigation in superficial bladder cancer followed by treatment with epodyl or mitomycin C at the time of first recurrence

INTERVENTION: Epodyl or mitomycin C Follow‐up: 3 monthly for 1st year, 6 monthly for 2nd year, annually thereafter. CONDITION: Bladder cancer ; Cancer ; Malignant neoplasm of bladder PRIMARY OUTCOME: Recurrence free survival SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: 1. Newly diagnosed superficial bladder cancer suitable for complete endoscopic resection 2. Transitional cell carcinoma limited to the bladder, no evidence of carcinoma in the upper tracts 3. World Health Organisation (WHO) performance status 0‐2 4. Expected survival at least 3 years 5. White count greater than 3 x 10^9/L and platelets greater than 100 x 10^9/L 6. No untreated urinary tract infection